BIOMAT Database Logo BIOMAT Database Logo

The treatment of patients with chronic mucocutaneous candidosis and candida onychomycosis with ketoconazole. 1982

R J Hay, and Y M Clayton

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007654 Ketoconazole Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients. Nizoral,R-41400,R41,400,R41400,R 41400
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D002177 Candidiasis Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases
D002178 Candidiasis, Chronic Mucocutaneous A clinical syndrome characterized by development, usually in infancy or childhood, of a chronic, often widespread candidiasis of skin, nails, and mucous membranes. It may be secondary to one of the immunodeficiency syndromes, inherited as an autosomal recessive trait, or associated with defects in cell-mediated immunity, endocrine disorders, dental stomatitis, or malignancy. Candidiases, Chronic Mucocutaneous,Chronic Mucocutaneous Candidiases,Chronic Mucocutaneous Candidiasis,Mucocutaneous Candidiases, Chronic,Mucocutaneous Candidiasis, Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R J Hay, and Y M Clayton
Proximal subungual Candida onychomycosis. An unusual manifestation of chronic mucocutaneous candidosis.
August 1997, The British journal of dermatology,
R J Hay, and Y M Clayton
Ketoconazole is effective against the chronic mucocutaneous candidosis of autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED).
January 1986, Acta medica Scandinavica,
R J Hay, and Y M Clayton
Chronic mucocutaneous candidosis and other superficial and systemic mycoses successfully treated with ketoconazole.
January 1980, Reviews of infectious diseases,
R J Hay, and Y M Clayton
Treatment of chronic mucocutaneous candidosis with ketoconazole: preliminary results of a controlled, double-blind clinical trial.
January 1980, Reviews of infectious diseases,
R J Hay, and Y M Clayton
Chronic mucocutaneous candidosis.
September 1988, International journal of dermatology,
R J Hay, and Y M Clayton
Ketoconazole treatment of chronic mucocutaneous candidiasis.
October 1980, Archives of dermatology,
R J Hay, and Y M Clayton
Ketoconazole treatment of chronic mucocutaneous candidiasis.
January 1986, Drugs under experimental and clinical research,
R J Hay, and Y M Clayton
Successful treatment of chronic mucocutaneous candidiasis with ketoconazole.
October 1980, The Journal of pediatrics,
R J Hay, and Y M Clayton
Successful treatment of chronic esophageal candidosis with oral ketoconazole.
August 1982, Mykosen,
R J Hay, and Y M Clayton
Management of chronic mucocutaneous candidosis.
September 1981, Clinical and experimental dermatology,
Copied contents to your clipboard!